Dr. Reddy's Laboratories Inc.
Dr. Reddy's Laboratories Inc., a prominent player in the global pharmaceutical industry, is headquartered in the United States and operates extensively across key regions including Europe, Asia, and Africa. Founded in 1984, the company has established itself as a leader in the development and manufacturing of a diverse range of pharmaceutical products, including generics, active pharmaceutical ingredients (APIs), and proprietary medicines. With a commitment to quality and innovation, Dr. Reddy's offers unique solutions that cater to various therapeutic areas, such as oncology, cardiovascular, and diabetes care. The company has achieved significant milestones, including numerous product approvals and a robust pipeline of new therapies, solidifying its market position. Renowned for its dedication to affordable healthcare, Dr. Reddy's Laboratories continues to make a meaningful impact on global health outcomes.
DitchCarbon Score
How does Dr. Reddy's Laboratories Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Dr. Reddy's Laboratories Inc.'s score of 41 is higher than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Dr. Reddy's Laboratories Inc.'s reported carbon emissions
Dr. Reddy's Laboratories Inc., headquartered in the US, currently does not have available data on its carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This lack of data suggests that the company may still be in the early stages of formalising its climate commitments or reporting on its emissions. In the pharmaceutical industry, companies are increasingly focusing on sustainability and reducing their carbon footprints, which may indicate a potential for future commitments from Dr. Reddy's Laboratories.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Dr. Reddy's Laboratories Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
